Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterine Cervical Neoplasms | 12 | 2006 | 285 | 1.730 |
Why?
|
| Insulin-Like Growth Factor II | 7 | 2005 | 52 | 1.220 |
Why?
|
| Uterine Cervical Dysplasia | 5 | 2005 | 44 | 0.980 |
Why?
|
| Spermatozoa | 12 | 1995 | 75 | 0.840 |
Why?
|
| Endometriosis | 8 | 2000 | 56 | 0.840 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 5 | 2005 | 46 | 0.840 |
Why?
|
| ErbB Receptors | 5 | 2005 | 239 | 0.810 |
Why?
|
| Infertility, Male | 9 | 1993 | 35 | 0.650 |
Why?
|
| Vascular Endothelial Growth Factor C | 2 | 2005 | 7 | 0.520 |
Why?
|
| Biomarkers, Tumor | 3 | 2005 | 508 | 0.520 |
Why?
|
| Papillomaviridae | 3 | 2005 | 87 | 0.500 |
Why?
|
| Antibodies | 7 | 2000 | 241 | 0.490 |
Why?
|
| Sperm Motility | 8 | 1995 | 41 | 0.460 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2005 | 219 | 0.440 |
Why?
|
| Papillomavirus Infections | 2 | 2005 | 163 | 0.430 |
Why?
|
| Autoantigens | 6 | 1995 | 91 | 0.420 |
Why?
|
| Blood Proteins | 4 | 2000 | 94 | 0.400 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2005 | 624 | 0.380 |
Why?
|
| Transferrin | 3 | 2000 | 94 | 0.350 |
Why?
|
| Infertility, Female | 5 | 2000 | 25 | 0.340 |
Why?
|
| Nicotine | 3 | 2005 | 350 | 0.340 |
Why?
|
| Oncogene Proteins, Viral | 3 | 2005 | 21 | 0.330 |
Why?
|
| Endometrium | 4 | 1995 | 31 | 0.320 |
Why?
|
| Cervix Uteri | 4 | 2001 | 64 | 0.280 |
Why?
|
| Autoantibodies | 8 | 1991 | 434 | 0.280 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2003 | 507 | 0.280 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2005 | 8 | 0.270 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2005 | 5 | 0.250 |
Why?
|
| Papanicolaou Test | 1 | 2005 | 54 | 0.250 |
Why?
|
| Vaginal Smears | 1 | 2005 | 78 | 0.250 |
Why?
|
| Autoimmunity | 4 | 2000 | 118 | 0.240 |
Why?
|
| Repressor Proteins | 2 | 2005 | 182 | 0.240 |
Why?
|
| Genital Neoplasms, Female | 1 | 2003 | 37 | 0.220 |
Why?
|
| Sperm Capacitation | 3 | 1993 | 8 | 0.210 |
Why?
|
| Female | 30 | 2006 | 38021 | 0.210 |
Why?
|
| Fluorescent Antibody Technique | 6 | 2003 | 282 | 0.200 |
Why?
|
| Myometrium | 1 | 1999 | 5 | 0.170 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 1999 | 40 | 0.170 |
Why?
|
| Humans | 36 | 2006 | 68549 | 0.170 |
Why?
|
| Calcium Channels | 1 | 1999 | 59 | 0.170 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1999 | 66 | 0.170 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 1999 | 56 | 0.160 |
Why?
|
| Antigens | 2 | 1988 | 90 | 0.150 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 700 | 0.150 |
Why?
|
| Autoimmune Diseases | 2 | 1990 | 186 | 0.150 |
Why?
|
| alpha-2-HS-Glycoprotein | 4 | 2000 | 11 | 0.140 |
Why?
|
| Calcium | 1 | 1999 | 929 | 0.130 |
Why?
|
| Immunoglobulin G | 4 | 1994 | 481 | 0.120 |
Why?
|
| Molecular Weight | 6 | 1995 | 358 | 0.120 |
Why?
|
| Semen | 3 | 1990 | 29 | 0.120 |
Why?
|
| Up-Regulation | 3 | 2005 | 682 | 0.110 |
Why?
|
| Immunization | 2 | 1995 | 86 | 0.110 |
Why?
|
| Endometrial Neoplasms | 2 | 2003 | 69 | 0.110 |
Why?
|
| Cervix Mucus | 2 | 1988 | 8 | 0.100 |
Why?
|
| Antibodies, Fungal | 1 | 1990 | 9 | 0.090 |
Why?
|
| Ascitic Fluid | 4 | 1999 | 22 | 0.090 |
Why?
|
| Candida albicans | 1 | 1990 | 38 | 0.090 |
Why?
|
| Immunoglobulin A | 1 | 1990 | 79 | 0.090 |
Why?
|
| Leukocytes | 1 | 1990 | 99 | 0.090 |
Why?
|
| Immunoglobulin M | 1 | 1990 | 172 | 0.090 |
Why?
|
| Cell Line, Tumor | 2 | 2005 | 1851 | 0.090 |
Why?
|
| Varicocele | 1 | 1988 | 1 | 0.080 |
Why?
|
| Epithelial Cells | 2 | 2001 | 431 | 0.080 |
Why?
|
| Infant, Premature | 1 | 1990 | 284 | 0.080 |
Why?
|
| Infertility | 1 | 1988 | 26 | 0.080 |
Why?
|
| Preventive Medicine | 1 | 2006 | 48 | 0.070 |
Why?
|
| Community Networks | 1 | 2006 | 96 | 0.070 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 40 | 0.060 |
Why?
|
| Cell Division | 2 | 2003 | 541 | 0.060 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2005 | 24 | 0.060 |
Why?
|
| Male | 15 | 1995 | 37283 | 0.060 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 1990 | 66 | 0.060 |
Why?
|
| HeLa Cells | 1 | 2005 | 237 | 0.060 |
Why?
|
| Early Diagnosis | 1 | 2005 | 122 | 0.060 |
Why?
|
| Rabbits | 4 | 1996 | 509 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 110 | 0.060 |
Why?
|
| Nicotinic Agonists | 1 | 2005 | 111 | 0.060 |
Why?
|
| Hemagglutination Tests | 4 | 1991 | 16 | 0.060 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2003 | 42 | 0.060 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2003 | 14 | 0.060 |
Why?
|
| Folic Acid | 1 | 2003 | 121 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 73 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 799 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2005 | 444 | 0.050 |
Why?
|
| Adult | 8 | 2003 | 21379 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2005 | 384 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2003 | 447 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2003 | 308 | 0.050 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2001 | 13 | 0.050 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2001 | 95 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2003 | 258 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2006 | 581 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2003 | 267 | 0.050 |
Why?
|
| Pregnancy | 3 | 1999 | 2334 | 0.050 |
Why?
|
| Mucus | 2 | 1990 | 33 | 0.050 |
Why?
|
| Quality Control | 1 | 2000 | 81 | 0.050 |
Why?
|
| Models, Biological | 1 | 2005 | 981 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2005 | 1174 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 95 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2003 | 475 | 0.040 |
Why?
|
| Ryanodine | 1 | 1999 | 7 | 0.040 |
Why?
|
| Thapsigargin | 1 | 1999 | 18 | 0.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 1999 | 13 | 0.040 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1999 | 40 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 1753 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2003 | 756 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 1995 | 689 | 0.040 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 1990 | 75 | 0.040 |
Why?
|
| Oxytocin | 1 | 1999 | 124 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2000 | 1549 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 1999 | 2673 | 0.030 |
Why?
|
| Isoelectric Focusing | 1 | 1996 | 42 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 659 | 0.030 |
Why?
|
| Animals | 7 | 1996 | 20880 | 0.030 |
Why?
|
| Prognosis | 1 | 2000 | 2093 | 0.030 |
Why?
|
| Culture Media | 2 | 1993 | 155 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 1 | 1994 | 74 | 0.030 |
Why?
|
| Platelet Activating Factor | 1 | 1994 | 34 | 0.030 |
Why?
|
| Time Factors | 2 | 1995 | 4655 | 0.030 |
Why?
|
| Embryonic Development | 1 | 1994 | 100 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1995 | 765 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1993 | 77 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2005 | 7028 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1995 | 1040 | 0.030 |
Why?
|
| Sperm Count | 2 | 1990 | 14 | 0.030 |
Why?
|
| Antibodies, Neoplasm | 1 | 1991 | 6 | 0.020 |
Why?
|
| Blotting, Western | 2 | 1990 | 954 | 0.020 |
Why?
|
| Leiomyoma | 1 | 1991 | 28 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 1745 | 0.020 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1990 | 22 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1990 | 30 | 0.020 |
Why?
|
| Uterine Neoplasms | 1 | 1991 | 99 | 0.020 |
Why?
|
| Isoantibodies | 1 | 1990 | 35 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 1990 | 63 | 0.020 |
Why?
|
| Protein Binding | 1 | 1993 | 1027 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1990 | 94 | 0.020 |
Why?
|
| Immunity | 1 | 1990 | 67 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 1990 | 546 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1990 | 126 | 0.020 |
Why?
|
| Gestational Age | 1 | 1990 | 389 | 0.020 |
Why?
|
| Monocytes | 1 | 1990 | 210 | 0.020 |
Why?
|
| Regression Analysis | 1 | 1990 | 737 | 0.020 |
Why?
|
| Coitus | 1 | 1988 | 12 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1990 | 397 | 0.020 |
Why?
|
| Immunoassay | 1 | 1988 | 64 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 1990 | 329 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1988 | 152 | 0.020 |
Why?
|
| Antibody Formation | 1 | 1988 | 93 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1987 | 18 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 1988 | 135 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2000 | 852 | 0.020 |
Why?
|
| Smoking | 1 | 1995 | 1449 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1987 | 351 | 0.020 |
Why?
|
| Social Justice | 1 | 2006 | 32 | 0.020 |
Why?
|
| Macrophages | 1 | 1990 | 647 | 0.020 |
Why?
|
| Social Class | 1 | 2006 | 127 | 0.020 |
Why?
|
| Adolescent | 1 | 1998 | 8904 | 0.020 |
Why?
|
| Papillomavirus Vaccines | 1 | 2006 | 82 | 0.020 |
Why?
|
| Middle Aged | 2 | 2003 | 21119 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 1990 | 2455 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1988 | 1465 | 0.010 |
Why?
|
| Age Factors | 1 | 1988 | 1860 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2006 | 955 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 160 | 0.010 |
Why?
|
| Mice | 2 | 1994 | 8474 | 0.010 |
Why?
|
| Rats | 1 | 1988 | 5300 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2006 | 2004 | 0.010 |
Why?
|
| South Carolina | 1 | 2006 | 2752 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 617 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2003 | 2356 | 0.010 |
Why?
|
| Spodoptera | 1 | 1996 | 21 | 0.010 |
Why?
|
| Horses | 1 | 1994 | 20 | 0.010 |
Why?
|
| Blastocyst | 1 | 1994 | 17 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 376 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1994 | 181 | 0.010 |
Why?
|
| Sheep | 1 | 1994 | 128 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 1082 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1996 | 284 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 1446 | 0.010 |
Why?
|
| Cell Line | 1 | 1996 | 1752 | 0.010 |
Why?
|
| Estradiol | 1 | 1989 | 176 | 0.000 |
Why?
|
| Sperm-Ovum Interactions | 1 | 1988 | 7 | 0.000 |
Why?
|
| Fertilization in Vitro | 1 | 1988 | 47 | 0.000 |
Why?
|
| Aged | 1 | 2003 | 14842 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1989 | 2550 | 0.000 |
Why?
|